Top Purchase Related
Home
>
Node
>
Subnode

Clopidogrel as basic therapy in high-risk stroke patients

Mattle, H.P.

Praxis 93(34): 1364

2004

ISSN/ISBN: 1661-8157
PMID: 15468694
Document Number: 574168

Document emailed within 1 workday
Secure & encrypted payments

Lim, S.; Mora-Pinzon, M.; Park, T.; Yoon, W.; Crisostomo, P.R.; Cho, J.S. 2019: Medical therapy does not confer stroke prevention for all patients: identification of high-risk patients with asymptomatic carotid stenosis is still needed International Angiology: a Journal of the International Union of Angiology 38(5): 372-380
Lala, A.; Berger, J.S. 2011: Percutaneous coronary intervention for acute coronary syndromes: no difference in 30-day efficacy or safety of high- and low-dose aspirin; double-dose clopidogrel reduces 30-day risk of cardiovascular death, myocardial infarction or stroke compared with standard dose but increases risk of major bleeding Evidence-Based Medicine 16(3): 80-81
Yang, J.; Zhou, J.-S.; Tan, J.; He, B.-S.; Zou, J.-J. 2012: Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients Die Pharmazie 67(12): 1026-1029
Yang, J.; Zhou, J.-S.; Zhao, Y.-X.; Yang, Z.-H.; Zhao, H.-D.; Zhang, Y.-D.; Zou, J.-J. 2015: ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patients Die Pharmazie 70(2): 97-102
Yang, J.; Zhou, J-Shan.; Zhang, Y-Dong.; Tian, Y-Yong.; Zou, J-Jun. 2014: The association of ABCC3 promoter methylation with clopidogrel response in Chinese ischemic stroke patients Die Pharmazie 69(10): 764-768
Woloszynska, I.; Stfpien, A. 2017: Risk Factors of Rt-Pa Therapy in Patients with Ischemic Stroke Acta Poloniae Pharmaceutica 74(1): 293-298
Costache, I.l.; Rusu, C.; Ivanov, I.; Popescu, R.; Petriş, A. 2012: Clopidogrel resistance--risk factor in patients with acute coronary syndromes Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(2): 383-388
Zuurbier, S.M.Yvonne.; Vermeer, S.E.; Hilkens, P.H.E.; Algra, A.; Roos, Y.B.W.E.M. 2013: Secondary prevention with clopidogrel after TIA or stroke Nederlands Tijdschrift Voor Geneeskunde 157(25): A5836
Phankingthongkum, R.; Panchavinnin, P.; Chinthammitr, Y.; Tresukosol, D.; Chotinaiwattarakul, C.; Tungsubutra, W.; Wongpraparut, N.; Kitrattana, B.; Leewanun, P. 2013: High on-clopidogrel treatment platelet reactivity in Thai patients with chronic stable angina scheduled for percutaneous coronary intervention Journal of the Medical Association of Thailand 96(5): 538-543
Baltás, B.; Nagy, A.; Baradnay, G.; Pepó, J. 1980: Experience with prophylactic cimetidine therapy in high risk patients Orvosi Hetilap 121(50): 3043-3047
Krone, W.; Müller-Wieland, D. 1991: Drug therapy of high risk patients with diabetes mellitus Verhandlungen der Deutschen Gesellschaft für Innere Medizin 97: 238-242
Adams, H.P.; Brott, T.G.; Furlan, A.J.; Gomez, C.R.; Grotta, J.; Helgason, C.M.; Kwiatkowski, T.; Lyden, P.D.; Marler, J.R.; Torner, J.; Feinberg, W.; Mayberg, M.; Thies, W. 1996: Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association Circulation 94(5): 1167-1174
Neilan, L. 1976: Estrogen therapy intrahepatic cholestasis: Characteristics of high-risk patients Journal of the American Medical Women's Association 31(3): 97-104
Akhtar, M.; Avitall, B.; Jazayeri, M.; Tchou, P.; Troup, P.; Sra, J.; Axtell, K. 1992: Role of implantable cardioverter defibrillator therapy in the management of high-risk patients Circulation 85(1): I131-I139
Cortesini, R.; Molajoni, E.R.; Berloco, P.; Bachetoni, A.; Cinti, P.; Trovati, A.; Sallusto, F.; Pretagostini, R.; Iapelli, M.; Caricato, M. 1989: Long-term follow-up of kidney grafts in high-risk patients under TLi and CsA therapy Transplantation Proceedings 21(1 Part 2): 1790-1792
Guthrie, R.M. 2015: The use of dual antiplatelet therapy in high-risk patients with acute coronary syndromes Journal of Family Practice 64(12 Suppl)
Sulimov, V.A.; Malova, E.V.; Syrkin, A.L.; Giliarov, M.I.; Novikova, N.A. 2006: Effectiveness and safety of clopidogrel bisulfate in complex therapy of patients with acute coronary syndrome with ST segment elevation Kardiologiia 46(7): 26-32
Hermanides, R.S.; Ottervanger, J.P.; ten Berg, J.M.; Gosselink, A.T.M.; van Houwelingen, G.; Dambrink, J.-H.E.; Stella, P.R.; Hamm, C.; van 't Hof, A.W.J. 2012: Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score Journal of Invasive Cardiology 24(3): 84-89
Levi, C.R.; Magin, P.J.; Nair, B.R. 2002: Primary stroke prevention: refining the "high risk" approach Medical Journal of Australia 176(7): 303-304
Hanchaiphiboolkul, S.; Poungvarin, N.; Nidhinandana, S.; Suwanwela, N.C.; Puthkhao, P.; Towanabut, S.; Tantirittisak, T.; Suwantamee, J.; Samsen, M. 2011: Prevalence of stroke and stroke risk factors in Thailand: Thai Epidemiologic Stroke (TES) Study Journal of the Medical Association of Thailand 94(4): 427-436